The Use of Standardized Reporting and Time-in-Range in the Management of Diabetes: A Consensus Report — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
The Use of Standardized Reporting and Time-in-Range in the Management of Diabetes: A Consensus Report
Endocrinology and Diabetes Department, Alhada and Taif Armed Forces Hospitals, Taif, Saudi Arabia
,
Pediatrics Department, King Abdulaziz Medical City—Ministry of National Guard Health Affairs, King Khalid National Guard Hospital, Jeddah, Saudi Arabia
,
Pediatrics Department, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
,
Endocrinology Department, King Salman hospital, Riyadh, Saudi Arabia
,
Endocrinology Department, Security forces hospital program, Riyadh, Saudi Arabia
,
Endocrinology Department, Prince Sultan Military Medical City (PSMMC), Riyadh, Saudi Arabia
,
Pediatrics Department, Ministry of National Guard Health Affairs-Riyadh, Riyadh, Saudi Arabia
,
Endocrinology Department, Taibah University, Madina, Saudi Arabia
,
Internal Medicine Department, King Abdulaziz Medical City—National Guard, Riyadh, Saudi Arabia
,
Endocrinology Department, Medical Director, OEMC, King Fahad Medical City, Riyadh, Saudi Arabia
,
Internal Medicine Department, Faculty of Medicine, Ain-Shams University, Cairo, Egypt
1 Endocrinology and Diabetes Department, Alhada and Taif Armed Forces Hospitals, Taif, Saudi Arabia
2 Pediatrics Department, King Abdulaziz Medical City—Ministry of National Guard Health Affairs, King Khalid National Guard Hospital, Jeddah, Saudi Arabia
3 Pediatrics Department, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
4 Endocrinology Department, King Salman hospital, Riyadh, Saudi Arabia
5 Endocrinology Department, Security forces hospital program, Riyadh, Saudi Arabia
6 Endocrinology Department, Prince Sultan Military Medical City (PSMMC), Riyadh, Saudi Arabia
7 Pediatrics Department, Ministry of National Guard Health Affairs-Riyadh, Riyadh, Saudi Arabia
8 Endocrinology Department, Taibah University, Madina, Saudi Arabia
9 Internal Medicine Department, King Abdulaziz Medical City—National Guard, Riyadh, Saudi Arabia
10 Endocrinology Department, Medical Director, OEMC, King Fahad Medical City, Riyadh, Saudi Arabia
11 Internal Medicine Department, Faculty of Medicine, Ain-Shams University, Cairo, Egypt
Introduction: The exhaustion of healthcare resources due to the rising prevalence in Saudi Arabia mandates the search for each method that can help in better control of diabetes. Methods: The gathered task force gath-ered to develop an explicit, evidence-based consensus for the use of time-in-range targets as guidance for better glycemic control while using continuous glucose monitoring (CGM). This article has the recommenda-tions of this expert panel. Results: HbA1c and self-monitoring blood glu-cose (SMBG) are not enough to detect blood glucose (BG) fluctuations on a daily basis. The incorporation of technology like FreeStyle Libre with its applications like Libre View is now used in many institutes in Saudi Ara-bia. This system is comprehensive and has all the standardized metrics needed. However, training and support are always needed. Barriers and challenges include the awareness & experience of the technology, the time barrier, the patients’ barriers, the technical barriers, and of course, the availability barrier. All the barriers and challenges should be dealt with by designing new training programs. Conclusion: The expert panel recom-mended using CGMs technology in people with type 1 diabetes (T1DM) children and adults, type 2 diabetes (T2DM) on multiple insulin injections, gestational diabetes (GDM) who need further glycemic control, and those at high risk for hypoglycemia. In addition, we recommend using them for a short period for those who require intensive BG control or during acute illness or stress. In addition, Ambulatory Glucose Profile (AGP) could be used as an educational tool for any individuals with DM to study the im-pact of certain elements of lifestyle modifications on their immediate BG level.
KeywordsDiabetesTime in RangeGlycemic ControlHbA1c
International Diabetes Federation (2017) IDF Diabetes Atlas. 8th Edition, International Diabetes Federation, Brussels. http://www.diabetesatlas.org
Al Dawish, M.A., Robert, A.A., Braham, R., Al Hayek, A.A., Al Saeed, A., Ahmed, R.A., et al. (2016) Diabetes Mellitus in Saudi Arabia: A Review of the Recent Literature. Current Diabetes Reports, 12, 359-368. https://doi.org/10.2174/1573399811666150724095130
Battelino, T., Danne, T., Bergenstal, R.M., Amiel, S.A., Beck, R., Biester, T., et al. (2019) Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations from the International Consensus on Time in Range. Diabetes Care, 42, 1593-1603. https://doi.org/10.2337/dci19-0028
Kirkwood, M. (2019) New Recommendations for Time-in-Range Targets during Continuous Glucose Monitoring Presented Today at the ADA’s Scientific Sessions. http://www.diabetes.org/newsroom/press-releases/2019/new-recommendations-for.html
Kohnert, K.D., Heinke, P., Vogt, L. and Salzsieder, E. (2015) Utility of Different Glycemic Control Metrics for Optimizing Management of Diabetes. World Journal of Diabetes, 6, 17-29. https://doi.org/10.4239/wjd.v6.i1.17
Hinzmann, R., Schlaeger, C. and Tran, C.T. (2012) What Do We Need beyond Hemoglobin A1c to Get the Complete Picture of Glycemia in People with Diabetes? International Journal of Medical Sciences, 9, 665-681. https://doi.org/10.7150/ijms.4520
Orchard, T.J., Nathan, D.M., Zinman, B., et al. (2015) Writing Group for the DCCT/ EDIC Research Group. Association between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-Term Mortality. JAMA, 313, 45-53. https://doi.org/10.1001/jama.2014.16107
Holman, R.R., Paul, S.K., Bethel, M.A., Matthews, D.R. and Neil, H.A.W. (2008) 10-Year Follow-Up of Intensive Glucose Control in Type 2 Diabetes. The New England Journal of Medicine, 359, 1577-1589. https://doi.org/10.1056/NEJMoa0806470
Danne, T., Nimri, R., Battelino, T., Bergenstal, R.M., Close, K.L., DeVries, J.H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S.A., Beck, R., Bosi, E., Buckingham, B., Cobelli, C., Dassau, E., Doyle, F. J., Heller, S., Hovorka, R., Jia, W., Phillip, M., et al. (2017) International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care, 40, 1631-1640. https://doi.org/10.2337/dc17-1600
Bry, L., Chen, P.C. and Sacks, D.B. (2001) Effects of Hemoglobin Variants and Chemically Modified Derivatives on Assays for Glycohemoglobin. Clinical Chemistry, 47, 153-163. https://doi.org/10.1093/clinchem/47.2.153
Ford, E.S., Cowie, C.C., Li, C., Handelsman, Y. and Bloomgarden, Z.T. (2011) Iron-Deficiency Anemia, Noniron-Deficiency Anemia and HbA1c among Adults in the US. Journal of Diabetes, 3, 67-73. https://doi.org/10.1111/j.1753-0407.2010.00100.x
Nielsen, L.R., Ekbom, P., Damm, P., et al. (2004) HbA1c Levels Are Significantly Lower in Early and Late Pregnancy. Diabetes Care, 27, 1200-1201. https://doi.org/10.2337/diacare.27.5.1200
Krhac, M. and Lovrencic, M.V. (2019) Update on Biomarkers of Glycemic Control. World Journal of Diabetes, 10, 1-15. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347654/ https://doi.org/10.4239/wjd.v10.i1.1
Lenters-Westra, E., Schindhelm, R.K., Bilo, H.J. and Slingerland, R.J. (2013) Haemoglobin A1c: Historical Overview and Current Concepts. Diabetes Research and Clinical Practice, 99, 75-84. https://doi.org/10.1016/j.diabres.2012.10.007
Kato, N., Cui, J. and Kato, M. (2013) Structured Self-Monitoring of Blood Glucose Reduces Glycated Hemoglobin in Insulin-Treated Diabetes. Journal of Diabetes Investigation, 4, 450-453. https://doi.org/10.1111/jdi.12072
Polonsky, W.H., Fisher, L., Schikman, C.H., et al. (2011) Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes: Results from the Structured Testing Program study. Diabetes Care, 34, 262-267. https://doi.org/10.2337/dc10-1732
Franciosi, M., Lucisano, G., Pellegrini, F., et al. (2011) ROSES Study Group. ROSES: Role of Self-Monitoring of Blood Glucose and Intensive Education in Patients with Type 2 Diabetes not Receiving Insulin. A Pilot Randomized Clinical Trial. Diabetic Medicine, 28, 789-796. https://doi.org/10.1111/j.1464-5491.2011.03268.x
Kempf, K., Kruse, J. and Martin, S. (2012) ROSSO-In-Praxi Follow-Up: Long-Term Effects of Self-Monitoring of Blood Glucose on Weight, hemoglobin A1c, and Quality of Life in Patients with Type 2 Diabetes Mellitus. Diabetes Technology & Therapeutics, 14, 59-64. https://doi.org/10.1089/dia.2011.0116
Gold, A.E., MacLeod, K.M. and Frier, B.M. (1994) Frequency of Severe Hypoglycemia in Patients with Type I Diabetes with Impaired Awareness of Hypoglycemia. Diabetes Care, 17, 697-703. https://doi.org/10.2337/diacare.17.7.697
Nathan, D.M., Genuth, S., Lachin, J., et al. (1993) Diabetes Control and Complications Trial Research Group. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications In insulin-Dependent Diabetes Mellitus. The New England Journal of Medicine, 329, 977-986. https://doi.org/10.1056/NEJM199309303291401
Miller, K.M., Beck, R.W., Bergenstal, R.M., et al. (2013) T1D Exchange Clinic Network. Evidence of a Strong Association between Frequency of Selfmonitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry Participants. Diabetes Care, 36, 2009-2014. https://doi.org/10.2337/dc12-1770
Pickup, J.C., Freeman, S.C. and Sutton, A.J. (2011) Glycaemic Control in Type 1 Diabetes during Real Time Continuous Glucose Monitoring Compared with Self Monitoring of Blood Glucose: Meta-Analysis of Randomised Controlled Trials Using Individual Patient Data. BMJ, 343. https://doi.org/10.1136/bmj.d3805
Evans, M., Welsh, Z., Ells, S. and Seibold, A. (2020) The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: A Meta-Analysis of Clinical Trials and Real-World Observational Studies. Diabetes Therapy, 11, 83-95. https://doi.org/10.1007/s13300-019-00720-0
Ajjan, R.A., Cummings, M.H., Jennings, P., Leelarathna, L., Rayman, G. and Wilmot, E.G. (2018) Accuracy of Flash Glucose Monitoring and Continuous Glucose Monitoring Technologies: Implications for Clinical Practice. Diabetes and Vascular Disease Research, 15, 175-184. https://doi.org/10.1177/1479164118756240
Beck, R.W., Bergenstal, R.M., Cheng, P., et al. (2019) The Relationships between Time in Range, Hyperglycemia Metrics, and HbA1c. Journal of Diabetes Science and Technology, 13, 614-626. https://doi.org/10.1177/1932296818822496
Vigersky, R.A. and McMahon, C. (2019) The Relationship of Hemoglobin A1C to Time-In-Range in Patients with Diabetes. Diabetes Technology & Therapeutics, 21, 81-85. https://doi.org/10.1089/dia.2018.0310
Beck, R.W., Bergenstal, R.M., Riddlesworth, T.D., Kollman, C., Li, Z., Brown, A.S., et al. (2019) Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials. Diabetes Care, 42, 400-405. https://doi.org/10.2337/dc18-1444
Rodbard, D. (2009) Interpretation of Continuous Glucose Monitoring Data: Glycemic Variability and Quality of Glycemic Control. Diabetes Technology & Therapeutics, 11, S55-S67. https://doi.org/10.1089/dia.2008.0132
Monnier, L., Colette, C., Wojtusciszyn, A., et al. (2017) Toward Defining the Threshold between Low and High Glucose Variability in Diabetes. Diabetes Care, 40, 832-838. https://doi.org/10.2337/dc16-1769
Devries, J.H. (2013) Glucose Variability: Where It Is Important and How to Measure It. Diabetes, 62, 1405-1408. https://doi.org/10.2337/db12-1610
Hirsch, I.B. (2015) Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does! Diabetes Care, 38, 1610-1614. https://doi.org/10.2337/dc14-2898
Bergenstal, R.M. (2015) Glycemic Variability and Diabetes Complications: Does It Matter? Simply Put, There Are Better Glycemic Markers! Diabetes Care, 38, 1615-1621. https://doi.org/10.2337/dc15-0099
Rodbard, D. (2012) The Challenges of Measuring Glycemic Variability. Journal of Diabetes Science and Technology, 6, 712-715. https://doi.org/10.1177/193229681200600328
Kovatchev, B. and Cobelli, C. (2016) Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes. Diabetes Care, 39, 502-510. https://doi.org/10.2337/dc15-2035
Cox, D.J., Kovatchev, B.P., Julian, D.M., et al. (1994) Frequency of Severe Hypoglycemia in Insulin-Dependent Diabetes Mellitus Can Be Predicted from Self-Monitoring Blood Glucose Data. The Journal of Clinical Endocrinology and Metabolism, 79, 1659-1662. https://doi.org/10.1210/jc.79.6.1659
Kovatchev, B.P., Flacke, F., Sieber, J. and Breton, M.D. (2014) Accuracy and Robustness of Dynamical Tracking of Average Glycemia (A1c) to Provide Real-Time Estimation of Hemoglobin A1c Using Routine Selfmonitored Blood Glucose Data. Diabetes Technology & Therapeutics, 16, 303-309. https://doi.org/10.1089/dia.2013.0224
Egi, M., Bellomo, R., Stachowski, E., French, C.J. and Hart, G. (2006) Variability of Blood Glucose Concentration and Short-Term Mortality in Critically Ill Patients. Anesthesiology, 105, 244-252. https://doi.org/10.1097/00000542-200608000-00006
Eslami, S., Taherzadeh, Z., Schultz, M.J and Abu-Hanna, A. (2011) Glucose Variability Measures and Their Effect on Mortality: A Systematic Review. Intensive Care Medicine, 37, 583-593. https://doi.org/10.1007/s00134-010-2129-5
Qu, Y., Jacober, S.J., Zhang, Q., Wolka, L.L. and Devries, J.H. (2012) Rate of Hypoglycemia in Insulin-Treated Patients with Type 2 Diabetes Can Be Predicted from Glycemic Variability Data. Diabetes Technology & Therapeutics, 14, 1008-1012. https://doi.org/10.1089/dia.2012.0099
International Diabetes Center (2020) AGP—Ambulatory Glucose Profile: AGP Reports. http://www.agpreport.org/agp/agpreports
Medtronic (2020) New CareLink iPro Pattern Snapshot. https://professional.medtronicdiabetes.com/para/new-carelink_-ipro_-pattern-snapshot-report
Bergenstal, R.M., Ahmann, A.J., Bailey, T., et al. (2013) Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP). Diabetes Technology & Therapeutics, 15, 198-211. https://doi.org/10.1089/dia.2013.0051
Xing, D., Kollman, C., Beck, R.W., et al. (2011) Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Optimal Sampling Intervals to Assess Long-Term Glycemic Control Using Continuous Glucose Monitoring. Diabetes Technology & Therapeutics, 13, 351-358. https://doi.org/10.1089/dia.2010.0156